Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1249, 2000-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Is There a Role for Adjuvant High-Dose Interferon- -2b in the Management of Melanoma?
Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. :
Access to resources
Recommend
HLA expression predicts IFN- -2b response in melanoma?
Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. :
Sargramostim: potential adjuvant therapy in melanoma?
Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. :
Early, high-dose thyroxine benefits neonates with CH?
Inpharma, Vol. 1, Iss. 1237, 2000-01 ,pp. :
Is there still a place for high-dose methotrexate in paediatric ALL?
Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. :